News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Gagnon Robert E.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/16/2023 |
4
| Gagnon Robert E. (Director) has filed a Form 4 on Verastem, Inc.|
Txns:
| Granted 62,500 options to buy
@ $0.42, valued at
$26.3k
|
|
| 03/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/21/2022 |
4
| Gagnon Robert E. (CFO) has filed a Form 4 on Verastem, Inc.|
Txns:
| Sold 1,348 shares
@ $1.13, valued at
$1.5k
|
|
| 06/22/2022 |
4
| Gagnon Robert E. (CFO) has filed a Form 4 on Verastem, Inc.|
Txns:
| Sold 1,351 shares
@ $1.14, valued at
$1.5k
|
|
| 05/17/2022 |
4
| Gagnon Robert E. (CFO) has filed a Form 4 on Verastem, Inc.|
Txns:
| Granted 50,000 shares
@ $0
Sold 16,627 shares
@ $1.03, valued at
$17.1k
|
|
| 03/23/2022 |
4
| Gagnon Robert E. (CFO) has filed a Form 4 on Verastem, Inc.|
Txns:
| Sold 1,409 shares
@ $1.27, valued at
$1.8k
|
|
| 01/05/2022 |
4
| Gagnon Robert E. (CFO) has filed a Form 4 on Verastem, Inc.|
Txns:
| Sold 19,612 shares
@ $2.05, valued at
$40.2k
|
|
| 12/22/2021 |
4
| Gagnon Robert E. (CFO) has filed a Form 4 on Verastem, Inc.|
Txns:
| Sold 5,497 shares
@ $2.27, valued at
$12.5k
|
|
| 12/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/22/2020 |
4
| Gagnon Robert E. (CFO) has filed a Form 4 on Verastem, Inc.|
Txns:
| Granted 67,925 shares
@ $0
Granted 203,776 options to buy
@ $2.2, valued at
$448.3k
|
|
| 08/13/2020 |
4
| Gagnon Robert E. (CFO) has filed a Form 4 on Verastem, Inc.|
Txns:
| Granted 290,210 shares
@ $0 |
|
| 03/30/2020 |
4
| Gagnon Robert E. (CFO) has filed a Form 4 on Verastem, Inc.|
Txns:
| Granted 62,500 shares
@ $0 |
|
| 12/17/2019 |
4
| Gagnon Robert E. (CFO) has filed a Form 4 on Verastem, Inc.|
Txns:
| Granted 125,000 options to buy
@ $1.34, valued at
$167.5k
|
|
| 06/25/2019 |
4
| Gagnon Robert E. (CFO) has filed a Form 4 on Verastem, Inc.|
Txns:
| Granted 100,000 shares
@ $0
Granted 250,000 options to buy
@ $1.81, valued at
$452.5k
|
|
| 01/07/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/30/2018 |
4
| Gagnon Robert E. (CFO) has filed a Form 4 on Verastem, Inc.|
Txns:
| Granted 50,000 shares
@ $0
Granted 350,000 options to buy
@ $9.43, valued at
$3.3M
|
|
| 08/30/2018 |
3
| Gagnon Robert E. (CFO) has filed a Form 3 on Verastem, Inc. |
| 08/30/2018 |
4
| Gagnon Robert E. (CFO) has filed a Form 4 on HARVARD BIOSCIENCE INC|
Txns:
| Sold 8,889 shares
@ $5.77, valued at
$51.3k
|
|
| 08/13/2018 |
4
| Gagnon Robert E. (CFO) has filed a Form 4 on HARVARD BIOSCIENCE INC|
Txns:
| Paid exercise price by delivering 5,170 shares
@ $5.7, valued at
$29.5k
|
|
| 08/09/2018 |
4
| Gagnon Robert E. (CFO) has filed a Form 4 on HARVARD BIOSCIENCE INC|
Txns:
| Sold 100,015 shares
@ $6.08, valued at
$608.1k
Exercised 30,000 options to buy
@ $4.31, valued at
$129.3k
Exercised 20,000 options to buy
@ $4.12, valued at
$82.4k
Exercised 37,500 options to buy
@ $5.56, valued at
$208.5k
|
|
| 07/31/2018 |
4
| Gagnon Robert E. (CFO) has filed a Form 4 on HARVARD BIOSCIENCE INC|
Txns:
| Sold 62,514 shares
@ $5.54, valued at
$346.3k
Exercised 30,000 options to buy
@ $4.31, valued at
$129.3k
Exercised 20,000 options to buy
@ $4.12, valued at
$82.4k
|
|
| 07/26/2018 |
4
| Gagnon Robert E. (CFO) has filed a Form 4 on HARVARD BIOSCIENCE INC|
Txns:
| Sold 5,570 shares
@ $5.25, valued at
$29.2k
|
|
| 07/23/2018 |
4
| Gagnon Robert E. (CFO) has filed a Form 4 on HARVARD BIOSCIENCE INC|
Txns:
| Sold 1,100 shares
@ $5.25, valued at
$5.8k
Sold 1,465 shares
@ $5.25, valued at
$7.7k
|
|
| 07/16/2018 |
4
| Gagnon Robert E. (CFO) has filed a Form 4 on HARVARD BIOSCIENCE INC|
Txns:
| Sold 9,145 shares
@ $5.25, valued at
$48k
Sold 1,062 shares
@ $5.25, valued at
$5.6k
Exercised 5,828 options to buy
@ $4.12, valued at
$24k
|
|
| 07/11/2018 |
4
| Gagnon Robert E. (CFO) has filed a Form 4 on HARVARD BIOSCIENCE INC|
Txns:
| Sold 14,200 shares
@ $5.41, valued at
$76.8k
Sold 13,700 shares
@ $5.38, valued at
$73.7k
Sold 141,300 shares
@ $5.23, valued at
$739k
Exercised 14,200 options to buy
@ $4.31, valued at
$61.2k
Exercised 13,700 options to buy
@ $4.31, valued at
$59k
Exercised 62,100 options to buy
@ $4.31, valued at
$267.7k
Exercised 54,172 options to buy
@ $4.12, valued at
$223.2k
|
|
| 05/29/2018 |
4
| Gagnon Robert E. (CFO) has filed a Form 4 on HARVARD BIOSCIENCE INC|
Txns:
| Granted 40,000 shares
@ $0 |
|
| 05/08/2018 |
4
| Gagnon Robert E. (CFO) has filed a Form 4 on HARVARD BIOSCIENCE INC|
Txns:
| Paid exercise price by delivering 26,081 shares
@ $5, valued at
$130.4k
|
|
| 03/12/2018 |
4
| Gagnon Robert E. (CFO) has filed a Form 4 on HARVARD BIOSCIENCE INC|
Txns:
| Sold 97,087 shares
@ $4.62, valued at
$448.5k
|
|
| 01/04/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/30/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|
|